Wolverine Trading, LLC Arcturus Therapeutics Holdings Inc. Put Options Transaction History

Wolverine Trading, LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$17.71 - $32.97 $46,046 - $85,722	2,600 Added 20.47%	15,300 $482,000
Q3 2023 Nov 15, 2023	SELL	$25.44 - $37.35 $170,448 - $250,245	-6,700 Reduced 34.54%	12,700 $324,000
Q2 2023 Aug 23, 2023	BUY	$23.94 - $32.36 $464,436 - $627,784	19,400 New	19,400 $556,000
Q2 2021 Aug 06, 2021	SELL	$25.79 - $42.11 $335,270 - $547,430	-13,000 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$38.75 - $86.92 $589,000 - $1.32 Million	-15,200 Reduced 53.9%	13,000 $504,000
Q4 2020 Feb 12, 2021	BUY	$34.61 - $123.66 $474,157 - $1.69 Million	13,700 Added 94.48%	28,200 $1.32 Million
Q3 2020 Nov 13, 2020	BUY	$37.49 - $63.19 $251,183 - $423,373	6,700 Added 85.9%	14,500 $620,000
Q2 2020 Aug 13, 2020	SELL	$12.66 - $58.27 $62,034 - $285,523	-4,900 Reduced 38.58%	7,800 $366,000
Q1 2020 May 11, 2020	BUY	$9.31 - $18.26 $118,237 - $231,902	12,700 New	12,700 $168,000

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $487M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.